Tradestie Institutional Equity Comparison Engine

NERV vs NEON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NERV Overall Edge

NERV Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Minerva Neurosciences, Inc (NERV) driven by superior Growth & Margin, Momentum & Technical while NEON counters with relative strength in Valuation, Options & Structure. Fundamentally, NERV trades at 11.2x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NEON at 9.3x Forward P/E and -604.4% operating margin (-20.4% YoY). In options structure, NERV sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against NEON sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NEON
NERV 11.2x vs NEON 9.3x Fwd P/E
Growth & Margin Winner NERV
Op Margin 0.0% vs -604.4% ยท YoY +0.0% vs -20.4%
Momentum & Technical Winner NERV
1Y -53.5% vs -76.2% ยท 52W Pos 1% vs 0%
Options & Structure Winner NEON
BREAKDOWN (100th %ile IV) vs UNCLASSIFIED (50th %ile IV)
NERV NASDAQ
Minerva Neurosciences, Inc
Pharmaceutical Preparations
$2.00
-5.66% 1D
Market Cap $105.7M
1M Return -16.67%
1Y Return -53.49%
Forward P/E 11.2x
Unified AI Score
43.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0
NEON NASDAQ
Neonode Inc. Common Stock
Electronic Components, Nec
$0.48
-7.69% 1D
Market Cap $8.7M
1M Return -36.21%
1Y Return -76.24%
Forward P/E 9.3x
Unified AI Score
39.8 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NERV -53.49% NEON -76.24% Spread: +22.75 pp (NERV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NERV TTM Op. Margin: 0.0% NEON TTM Op. Margin: -604.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NERV vs NEON. Trailing 12-month operating profitability (NERV 0.0% vs NEON -604.4%) and valuation multiples (NERV 11.2x vs NEON 9.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NERV (5) vs NEON (5)
Institutional Metric NERV NEON Criterion Row Winner
Market Capitalization Scale $105.7M $8.7M Larger Scale NERV
Trailing P/E Ratio Valuation 11.2x 9.3x Lower Multiple NEON
Forward P/E Ratio Valuation 11.2x 9.3x Lower Multiple NEON
Revenue Growth (YoY) Growth +0.0% -20.4% Higher Growth NERV
Operating Margin (TTM) Profitability 0.0% -604.4% Higher Margin NERV
Net Profit Margin Profitability 0.0% 397.8% Higher Margin NEON
Return on Equity (ROE) Capital Efficiency -675.1% 46.8% Higher ROE NEON
52-Week Range Position Momentum 1% ($2โ€“$9) 0% ($0โ€“$2) Stronger Trend NERV
Beta / 30D Volatility Risk Regime 1.63ฮฒ ยท 76% Vol 2.07ฮฒ ยท 63% Vol Lower Realized Risk NEON
Unified Institutional Score Composite Signal 43.3 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite NERV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NERV vs NEON Buy Guide
NERV BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live NERV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NEON UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NEON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NERV nor NEON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.